Monoclonal Antibody Trial Halted for Safety Concern | Brief19
▻https://brief19.com/2020/10/13/monoclonal-antibody-trial-halted-for-safety-concern
(En association avec le #remdesivir dans l’étude concernée appelée “ACTIV-3”)
This news casts doubt as to the wisdom and safety of the approach used by President Trump’s medical team.